Universe Pharmaceuticals INC (UPC)

Market Cap	6.98M +190.3%
Revenue (ttm)	17.74M -8.0%
Net Income	-1.94M
EPS	-3.45
Shares Out	5.02M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	13,052
Open	1.400
Previous Close	1.400
Day's Range	1.330 - 1.400
52-Week Range	1.330 - 17.960
Beta	1.85
Analysts	n/a
Price Target	n/a
Earnings Date	Jan 29, 2026

About UPC

Universe Pharmaceuticals INC, through its subsidiaries, engages in the manufacturing, marketing, distribution, and sales of traditional Chinese medicine derivative products in China. The company offers products for the treatment and relief of common chronic health conditions in the elderly for physical wellness and longevity; and cold and flu medications. It also provides guben yanling, shenrong weisheng, and quanlu pill; yangxue danggui and qiangli pipa syrup; wuzi yanzong oral, fengtong medicinal, shenrong medicinal, qishe medicinal, fengshit...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• IPO Date: Mar 23, 2021
• Employees: 216
• Stock Exchange: Nasdaq
• Ticker Symbol: UPC
• Website: https://www.universe-pharmacy.com

Financial Performance

In fiscal year 2025, UPC's revenue was $17.86 million, a decrease of -22.44% compared to the previous year's $23.02 million. Losses were -$3.67 million, -57.92% less than in 2024.

Data Sources: S&P Global Market Intelligence, CBOE, and more

Fundamental and historical data is provided by S&P Global Market Intelligence. Real-time stock price data is provided by CBOE and 15-minute delayed consolidated tape pricing data is provided by Nasdaq UTP.

Last checked:

Nov 6, 2026

Data Sources Report a data error